Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
3 trials
Recent
Start date
Enrollment
Phase 3
×
Carcinoma, Squamous Cell
×
pembrolizumab
×
Clear all
Filters
3
NCT03833167
2026-03-10
KEYNOTE-630
Merck Sharp & Dohme LLC
Phase 3
Completed
450 enrolled
18 charts
NCT04747054
2024-10-26
PembroMetaRT
UNICANCER
Phase 3
Recruiting
102 enrolled
NCT02252042
2023-07-17
MK-3475-040
Merck Sharp & Dohme LLC
Phase 3
Completed
495 enrolled
32 charts